Study of Aldafermin (NGM282) in Subjects With Compensated Cirrhosis (ALPINE 4)
Clinical trial NCT04210245 · COMPLETED
Trial details
- NCT number
- NCT04210245
- Sponsor
- NGM Biopharmaceuticals, Inc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-23
- Primary completion
- 2023-01-04
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.